Dagmar S.
- Country
- Slovakia
- Department
- Klinická a radiačná onkológia
Research Overview
- Evaluation of Pharmacokinetics, Efficacy, and Safety of BAT3306 with Chemotherapy Versus Pembrolizumab with Chemotherapy in Stage IV Non-squamous NSCLC
- Phase 3 Study of PF-07220060 and Fulvestrant Versus Investigator's Choice in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer Post-CDK 4/6 Inhibitor Therapy
- C4551002 - An Interventional, Open-Label, Randomized, Multicenter, Phase 3 Study of PF-07248144 Plus Fulvestrant Compared to Investigator’s Choice of Therapy in Adult Participants with Hormone Receptor-Positive, HER2-Negative Advanced/Metastatic Breast Cancer Whose Disease Progressed After Prior CDK4/6 Inhibitor-based Therapy
Data & Insights
Has run more than one trial at 39 of 182 partner sites.
Specializations
Breast Cancer Research
The investigator specializes in treating hormone receptor-positive, HER2-negative advanced breast cancer, with particular focus on developing therapeutic strategies for patients who have experienced disease progression after initial treatment.
- Advanced metastatic breast cancer management
- Hormone receptor-positive disease treatment
- Endocrine therapy combinations
Their work explores innovative combination therapies involving endocrine treatments for advanced breast cancer cases.
Lung Cancer Treatment
The investigator focuses on advanced non-squamous non-small cell lung cancer, particularly in stage IV disease. Their research encompasses novel therapeutic approaches in first-line treatment settings.
- Stage IV NSCLC treatment strategies
- Immunotherapy combinations
- Advanced lung cancer therapeutics
Their expertise extends to evaluating innovative immunotherapy approaches combined with chemotherapy regimens.
Head and Neck Cancer
The investigator specializes in treating recurrent and metastatic head and neck squamous cell carcinoma, with emphasis on developing advanced therapeutic combinations.
- Recurrent HNSCC management
- Metastatic disease treatment
- Immunotherapy applications
Their research explores novel treatment combinations involving targeted therapies and immunotherapeutic approaches.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.